Survival-Based Biomarker Module Identification Associated with Oral Squamous Cell Carcinoma (OSCC).
key genes
module
protein–protein interaction
survival rate
weighted network
Journal
Biology
ISSN: 2079-7737
Titre abrégé: Biology (Basel)
Pays: Switzerland
ID NLM: 101587988
Informations de publication
Date de publication:
08 Aug 2021
08 Aug 2021
Historique:
received:
13
07
2021
revised:
03
08
2021
accepted:
05
08
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
28
8
2021
Statut:
epublish
Résumé
Head and neck squamous cell carcinoma (HNSC) is one of the most common malignant tumors worldwide with a high rate of morbidity and mortality, with 90% of predilections occurring for oral squamous cell carcinoma (OSCC). Cancers of the mouth account for 40% of head and neck cancers, including squamous cell carcinomas of the tongue, floor of the mouth, buccal mucosa, lips, hard and soft palate, and gingival. OSCC is the most devastating and commonly occurring oral malignancy, with a mortality rate of 500,000 deaths per year. This has imposed a strong necessity to discover driver genes responsible for its progression and malignancy. In the present study we filtered oral squamous cell carcinoma tissue samples from TCGA-HNSC cohort, which we followed by constructing a weighted PPI network based on the survival of patients and the expression profiles of samples collected from them. We found a total of 46 modules, with 18 modules having more than five edges. The KM and ME analyses revealed a single module (with 12 genes) as significant in the training and test datasets. The genes from this significant module were subjected to pathway enrichment analysis for identification of significant pathways and involved genes. Finally, the overlapping genes between gene sets ranked on the basis of weighted PPI module centralities (i.e., degree and eigenvector), significant pathway genes, and DEGs from a microarray OSCC dataset were considered as OSCC-specific hub genes. These hub genes were clinically validated using the IHC images available from the Human Protein Atlas (HPA) database.
Identifiants
pubmed: 34439992
pii: biology10080760
doi: 10.3390/biology10080760
pmc: PMC8389591
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Indian Council of Medical Research
ID : BMI/11(89/2020
Organisme : Science and Engineering Research Board
ID : EEQ/2016/000509
Références
Nat Protoc. 2009;4(8):1184-91
pubmed: 19617889
Nat Biotechnol. 2010 Dec;28(12):1248-50
pubmed: 21139605
Nat Biotechnol. 2020 Jun;38(6):675-678
pubmed: 32444850
Sci Rep. 2017 Feb 08;7:42105
pubmed: 28176846
PLoS Genet. 2021 Feb 4;17(2):e1009283
pubmed: 33539340
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Sci Rep. 2015 Jun 23;5:11566
pubmed: 26099452
Nucleic Acids Res. 2015 Dec 2;43(21):e140
pubmed: 26184878
Br J Cancer. 2018 Jul;119(1):52-64
pubmed: 29899394
Cancer Lett. 2018 Dec 1;438:52-62
pubmed: 30213559
BMC Cancer. 2020 Jun 19;20(1):575
pubmed: 32560641
Biosystems. 2015 Jan;127:67-72
pubmed: 25451770
Cancer Immunol Immunother. 2005 Aug;54(8):729-40
pubmed: 15685448
mSphere. 2018 Jan 10;3(1):
pubmed: 29359188
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
PLoS One. 2014 Mar 25;9(3):e93102
pubmed: 24667986
Nature. 2012 Aug 30;488(7413):660-4
pubmed: 22895193
Science. 2011 Aug 26;333(6046):1157-60
pubmed: 21798893
Infect Agent Cancer. 2011 Mar 29;6:4
pubmed: 21447181
BMC Bioinformatics. 2004 Dec 16;5:199
pubmed: 15603590
Int J Cancer. 2014 Dec 15;135(12):2795-803
pubmed: 24771271
Genome Biol. 2014;15(12):550
pubmed: 25516281
Mol Cell Proteomics. 2005 Dec;4(12):1920-32
pubmed: 16127175
Cancer J. 2015 May-Jun;21(3):138-46
pubmed: 26049691
Science. 2011 Aug 26;333(6046):1154-7
pubmed: 21798897
Mol Cell Proteomics. 2008 Oct;7(10):2019-27
pubmed: 18669619
Heliyon. 2019 Jun 14;5(6):e01707
pubmed: 31338439
Mol Clin Oncol. 2020 Apr;12(4):299-310
pubmed: 32190310
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Nat Rev Cancer. 2018 May;18(5):269-282
pubmed: 29497144
Science. 2017 May 26;356(6340):
pubmed: 28495876
Asian Pac J Cancer Prev. 2013;14(2):1147-50
pubmed: 23621203
Clin Cancer Res. 2013 Mar 1;19(5):1197-203
pubmed: 23319825
Methods Mol Biol. 2016;1418:93-110
pubmed: 27008011
Immunity. 2014 Jun 19;40(6):936-48
pubmed: 24931123
Cell Biol Toxicol. 2018 Jun;34(3):207-218
pubmed: 29508110
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10101-6
pubmed: 10963673
J Cell Physiol. 2020 Jan;235(1):394-407
pubmed: 31225658
Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Apr;113(4):518-25
pubmed: 22668430
BMC Genomics. 2008 Feb 06;9:69
pubmed: 18254958
Science. 2017 Aug 18;357(6352):
pubmed: 28818916
World J Surg Oncol. 2018 May 2;16(1):89
pubmed: 29720180
Int J Cancer. 2013 Feb 1;132(3):540-8
pubmed: 22740306
Nature. 2012 Apr 04;486(7403):395-9
pubmed: 22495314
Cell Physiol Biochem. 2018;48(3):1151-1163
pubmed: 30045016
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
J BUON. 2018 Nov-Dec;23(6):1662-1670
pubmed: 30610792
Genes (Basel). 2019 Dec 04;10(12):
pubmed: 31817302
J Clin Invest. 2007 Oct;117(10):3107-17
pubmed: 17823654
Bioinformatics. 2005 Aug 15;21(16):3439-40
pubmed: 16082012
Front Immunol. 2018 Jan 17;8:1992
pubmed: 29387060
Oncoimmunology. 2015 Jun 1;4(12):e1052935
pubmed: 26587329
Laryngoscope. 2019 Nov;129(11):2506-2513
pubmed: 30637762